Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticholinergic Burden as a Modifiable Risk Factor in Cardiac Surgery
NCT06349057Phase 4Completed
- Sponsor
- Ankara City Hospital
- Start
- Jan 2024
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative complications (2 arms), sponsored by Ankara City Hospital. Primary endpoints: Katz Index of Independence in Activities of Daily Living and Clinical Frailty Scale. Started Jan 2024; status: completed.
02
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT06349057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06349057.